NCT02451865 Binimetinib With Docetaxel in Treating Patients With Previously Treated, Stage IV Non-small Cell Lung Cancer Status WITHDRAWN Phase PHASE1
NCT02450903 LDK378 in Patients With ALK Positive NSCLC Previously Treated With Alectinib. Status COMPLETED Phase PHASE2
NCT02449018 A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251 Status COMPLETED Phase PHASE2
NCT02445248 Study of Efficacy and Safety of CTL019 in Adult DLBCL Patients Status COMPLETED Phase PHASE2
NCT02442206 Effect of QVA149 (Indacaterol Maleate/Glycopyrronium Bromide) on Cardiac Function in COPD Patients Status COMPLETED Phase PHASE4
NCT02437318 Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant in Men and Postmenopausal Women With Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment. Status COMPLETED Phase PHASE3
NCT02435849 Study of Efficacy and Safety of CTL019 in Pediatric ALL Patients Status COMPLETED Phase PHASE2
NCT02435680 Efficacy Study of MCS110 Given With Carboplatin and Gemcitabine in Advanced Triple Negative Breast Cancer (TNBC) Status COMPLETED Phase PHASE2
NCT02435212 Study to Evaluate Treatment Compliance, Efficacy and Safety of an Improved Deferasirox Formulation (Granules) in Pediatric Patients (2-<18 Years Old) With Iron Overload Status COMPLETED Phase PHASE2
NCT02435173 Study of Efficacy of CDZ173 in Patients With APDS/PASLI Status COMPLETED Phase PHASE2/PHASE3
NCT02431481 Evaluation of Renal Function Impairment on the Pharmacokinetics of LEE011 Status COMPLETED Phase PHASE1
NCT02422615 Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer. Status COMPLETED Phase PHASE3
NCT02422589 A Phase I, Multi-center, Open Label, Drug-drug Interaction Study to Assess the Effect of Ceritinib on the Pharmacokinetics of Warfarin and Midazolam in Patients With ALK-positive Advanced Tumors Status COMPLETED Phase PHASE1
NCT02421172 Efficacy, Safety, and Pharmacokinetics Study of CJM112 in Hidradenitis Suppurativa Patients Status COMPLETED Phase PHASE2
NCT02418468 Effects of Indacaterol in Symptomatic COPD Patients With Low Risk of Exacerbations Status COMPLETED Phase PHASE4
NCT02414139 Study of Oral cMET Inhibitor INC280 in Patients With EGFR Wild-type (wt), Advanced Non-small Cell Lung Cancer (NSCLC) (Geometry Mono-1) Status COMPLETED Phase PHASE2